Matthew Edwards

Matthew Edwards is currently the Global Talent Acquisition Lead for Oncology R&D and Head of North America Talent Acquisition at AstraZeneca.24 He is based in Gaithersburg, Maryland, United States.3

Professional Experience

Matthew Edwards has an extensive background in the pharmaceutical and biotech industries, with experience in various leadership roles:

• AstraZeneca: Currently serving as Global Talent Acquisition Lead for Oncology R&D and Head of North America Talent Acquisition.24

• Johnson & Johnson:

  • Global Head Discovery and Translational Sciences (interim) from September 20231
  • Senior Director and Discovery Biology / Immunology Lead from October 20191

• GSK (GlaxoSmithKline):

  • Senior Director and Lead Immunologist from December 2016 to October 20191
  • Director and Lead Immunologist from July 2014 to October 20191

• Novartis:

  • Senior Investigator II - Head of Exacerbations from 2012 to June 20141
  • Senior Investigator I from 2010 to 20121
  • Investigator III from 2009 to 20101
  • Investigator II from 2005 to 20091
  • Postdoctoral Fellow from 2004 to 20051

Education

Matthew Edwards has a strong academic background in microbiology and immunology:

• Ph.D. in Viral Immunology from the University of Warwick (1995-1999)1
• M.Sc. in Molecular Virology with Distinction from the London School of Hygiene and Tropical Medicine (1994-1995)1
• B.Sc. (Hons) in Microbiology from the University of Wales, Cardiff (1991-1994)1

Research and Expertise

Throughout his career, Matthew has been involved in various research projects and leadership roles, focusing on areas such as:

• Asthma models and human immunological assays
• Respiratory diseases and allergic inflammation
• Exacerbation strategies for respiratory conditions
• Immunological assays related to innate host defense and allergy
• Project team leadership for therapeutic antibody projects

His extensive experience in both academic research and pharmaceutical industry roles has positioned him as a leader in talent acquisition for oncology and R&D in the pharmaceutical sector.